Jove
Visualize
Contact Us
  1. Home
  2. Padeliporfin Vascular-targeted Photodynamic Therapy Versus Active Surveillance In Men With Low-risk Prostate Cancer
  1. Home
  2. Padeliporfin Vascular-targeted Photodynamic Therapy Versus Active Surveillance In Men With Low-risk Prostate Cancer

Related Concept Videos

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer

Weigang Yan1, Yi Zhou1, Zhien Zhou1

  • 1Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.

The Lancet. Oncology
|April 4, 2017
Summary

No abstract available in PubMed .

Related Experiment Videos